Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hemangioma | 3 | 2021 | 84 | 1.360 |
Why?
|
| Vascular Malformations | 3 | 2020 | 103 | 1.220 |
Why?
|
| Cleft Palate | 7 | 2023 | 79 | 1.160 |
Why?
|
| Cleft Lip | 5 | 2024 | 46 | 0.940 |
Why?
|
| Pierre Robin Syndrome | 1 | 2021 | 7 | 0.720 |
Why?
|
| Receptors, Progesterone | 1 | 2021 | 66 | 0.700 |
Why?
|
| Receptors, Estrogen | 2 | 2021 | 132 | 0.690 |
Why?
|
| Osteogenesis, Distraction | 1 | 2021 | 78 | 0.690 |
Why?
|
| Lymphatic Abnormalities | 1 | 2019 | 20 | 0.630 |
Why?
|
| Vascular Neoplasms | 1 | 2018 | 17 | 0.590 |
Why?
|
| Laser Therapy | 1 | 2018 | 76 | 0.570 |
Why?
|
| Vascular Surgical Procedures | 1 | 2019 | 166 | 0.550 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2018 | 190 | 0.520 |
Why?
|
| Estrogens | 3 | 2008 | 223 | 0.490 |
Why?
|
| Aging | 3 | 2008 | 707 | 0.380 |
Why?
|
| Velopharyngeal Insufficiency | 2 | 2023 | 18 | 0.380 |
Why?
|
| Treatment Outcome | 7 | 2023 | 5486 | 0.320 |
Why?
|
| Interleukin-1 | 2 | 2006 | 105 | 0.300 |
Why?
|
| Lipopolysaccharides | 3 | 2008 | 206 | 0.290 |
Why?
|
| Infant | 7 | 2024 | 3720 | 0.250 |
Why?
|
| Blood Cells | 1 | 2005 | 37 | 0.230 |
Why?
|
| Humans | 20 | 2024 | 52593 | 0.230 |
Why?
|
| Surgical Flaps | 2 | 2023 | 110 | 0.220 |
Why?
|
| Microglia | 1 | 2005 | 113 | 0.210 |
Why?
|
| Blotting, Western | 2 | 2021 | 593 | 0.210 |
Why?
|
| Retrospective Studies | 8 | 2024 | 6671 | 0.210 |
Why?
|
| Vomer | 1 | 2023 | 1 | 0.210 |
Why?
|
| Female | 15 | 2024 | 28262 | 0.210 |
Why?
|
| Hemoglobins | 1 | 2024 | 111 | 0.210 |
Why?
|
| Preoperative Care | 1 | 2024 | 174 | 0.200 |
Why?
|
| Child, Preschool | 8 | 2024 | 4062 | 0.190 |
Why?
|
| RNA, Messenger | 2 | 2021 | 1139 | 0.190 |
Why?
|
| Gills | 1 | 2021 | 5 | 0.180 |
Why?
|
| Soft Tissue Injuries | 1 | 2021 | 17 | 0.180 |
Why?
|
| Lip | 1 | 2021 | 11 | 0.180 |
Why?
|
| Bites and Stings | 1 | 2021 | 20 | 0.180 |
Why?
|
| Facial Injuries | 1 | 2021 | 25 | 0.180 |
Why?
|
| Eustachian Tube | 1 | 2021 | 13 | 0.170 |
Why?
|
| Reoperation | 1 | 2023 | 465 | 0.170 |
Why?
|
| Air Microbiology | 1 | 2020 | 12 | 0.170 |
Why?
|
| Craniofacial Abnormalities | 1 | 2021 | 27 | 0.170 |
Why?
|
| Adenoidectomy | 1 | 2020 | 35 | 0.170 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2021 | 186 | 0.170 |
Why?
|
| Dermatologic Surgical Procedures | 1 | 2020 | 35 | 0.170 |
Why?
|
| Anesthesia | 1 | 2021 | 71 | 0.170 |
Why?
|
| Tonsillectomy | 1 | 2020 | 49 | 0.170 |
Why?
|
| Male | 10 | 2024 | 26863 | 0.170 |
Why?
|
| Receptors, Notch | 1 | 2020 | 28 | 0.170 |
Why?
|
| Lasers, Solid-State | 1 | 2020 | 31 | 0.170 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2020 | 52 | 0.170 |
Why?
|
| Patient Safety | 1 | 2021 | 104 | 0.160 |
Why?
|
| Veins | 1 | 2020 | 74 | 0.160 |
Why?
|
| Postoperative Complications | 2 | 2024 | 1081 | 0.160 |
Why?
|
| Surgical Wound Infection | 1 | 2020 | 117 | 0.160 |
Why?
|
| Respiratory Tract Infections | 1 | 2020 | 82 | 0.160 |
Why?
|
| Abnormalities, Multiple | 2 | 2018 | 168 | 0.160 |
Why?
|
| Neovascularization, Pathologic | 1 | 2020 | 158 | 0.160 |
Why?
|
| Child | 8 | 2024 | 7229 | 0.150 |
Why?
|
| Infant, Newborn | 4 | 2020 | 2891 | 0.150 |
Why?
|
| Dental Pulp Cavity | 1 | 2018 | 6 | 0.150 |
Why?
|
| Tooth Abnormalities | 1 | 2018 | 13 | 0.150 |
Why?
|
| Facial Bones | 1 | 2018 | 18 | 0.150 |
Why?
|
| Cryosurgery | 1 | 2018 | 36 | 0.150 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2018 | 67 | 0.150 |
Why?
|
| Face | 1 | 2018 | 56 | 0.140 |
Why?
|
| Patient Selection | 1 | 2019 | 266 | 0.140 |
Why?
|
| Brain | 1 | 2006 | 1325 | 0.140 |
Why?
|
| Ovariectomy | 3 | 2008 | 113 | 0.140 |
Why?
|
| Skin | 1 | 2020 | 418 | 0.140 |
Why?
|
| Gastroesophageal Reflux | 1 | 2017 | 48 | 0.140 |
Why?
|
| Algorithms | 1 | 2021 | 668 | 0.130 |
Why?
|
| Drug Interactions | 3 | 2008 | 205 | 0.130 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2017 | 43 | 0.130 |
Why?
|
| Deglutition Disorders | 1 | 2017 | 79 | 0.130 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 438 | 0.130 |
Why?
|
| Cell Proliferation | 1 | 2020 | 1029 | 0.130 |
Why?
|
| Salivary Glands | 1 | 2015 | 6 | 0.120 |
Why?
|
| Tongue Diseases | 1 | 2015 | 6 | 0.120 |
Why?
|
| Choristoma | 1 | 2015 | 23 | 0.120 |
Why?
|
| Tongue | 1 | 2015 | 40 | 0.120 |
Why?
|
| Mycophenolic Acid | 1 | 2014 | 19 | 0.110 |
Why?
|
| Dermis | 1 | 2014 | 19 | 0.110 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 1006 | 0.110 |
Why?
|
| Hair Follicle | 1 | 2014 | 36 | 0.110 |
Why?
|
| Animals | 4 | 2021 | 13507 | 0.110 |
Why?
|
| Risk Factors | 2 | 2020 | 3952 | 0.110 |
Why?
|
| beta Catenin | 1 | 2014 | 103 | 0.110 |
Why?
|
| Wnt Signaling Pathway | 1 | 2014 | 95 | 0.110 |
Why?
|
| Risk Assessment | 1 | 2018 | 1350 | 0.110 |
Why?
|
| Prognosis | 1 | 2018 | 2118 | 0.100 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 250 | 0.100 |
Why?
|
| Pharynx | 2 | 2023 | 31 | 0.100 |
Why?
|
| Prospective Studies | 3 | 2024 | 2457 | 0.090 |
Why?
|
| Rats | 3 | 2008 | 3203 | 0.090 |
Why?
|
| Cells, Cultured | 3 | 2014 | 1588 | 0.080 |
Why?
|
| Olfactory Bulb | 2 | 2008 | 14 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2008 | 396 | 0.070 |
Why?
|
| Astrocytes | 1 | 2008 | 138 | 0.060 |
Why?
|
| Corticosterone | 1 | 2006 | 18 | 0.060 |
Why?
|
| Time | 1 | 2006 | 29 | 0.060 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2006 | 28 | 0.060 |
Why?
|
| Transcription Factors | 2 | 2020 | 566 | 0.060 |
Why?
|
| Colorimetry | 1 | 2005 | 16 | 0.060 |
Why?
|
| Nitrites | 1 | 2005 | 31 | 0.060 |
Why?
|
| Nitrates | 1 | 2005 | 31 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2006 | 558 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 582 | 0.060 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2005 | 87 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 237 | 0.060 |
Why?
|
| Adolescent | 3 | 2020 | 6737 | 0.050 |
Why?
|
| Ecuador | 1 | 2023 | 4 | 0.050 |
Why?
|
| Peru | 1 | 2023 | 8 | 0.050 |
Why?
|
| Inflammation | 1 | 2008 | 644 | 0.050 |
Why?
|
| Gene Expression | 1 | 2006 | 623 | 0.050 |
Why?
|
| Lebanon | 1 | 2023 | 11 | 0.050 |
Why?
|
| Maxilla | 1 | 2023 | 14 | 0.050 |
Why?
|
| Uvula | 1 | 2023 | 13 | 0.050 |
Why?
|
| Occupational Injuries | 1 | 2023 | 31 | 0.050 |
Why?
|
| Osteotomy | 1 | 2023 | 32 | 0.050 |
Why?
|
| Musculoskeletal Diseases | 1 | 2023 | 51 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2005 | 244 | 0.050 |
Why?
|
| Cytokines | 1 | 2006 | 626 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2006 | 1554 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 984 | 0.050 |
Why?
|
| Head | 1 | 2022 | 70 | 0.050 |
Why?
|
| Personal Satisfaction | 1 | 2022 | 75 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 1378 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 747 | 0.040 |
Why?
|
| Photography | 1 | 2020 | 31 | 0.040 |
Why?
|
| Nasopharynx | 1 | 2020 | 34 | 0.040 |
Why?
|
| Health Personnel | 1 | 2023 | 252 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2020 | 116 | 0.040 |
Why?
|
| Developing Countries | 1 | 2021 | 63 | 0.040 |
Why?
|
| Curriculum | 1 | 2023 | 399 | 0.040 |
Why?
|
| Propranolol | 1 | 2020 | 78 | 0.040 |
Why?
|
| Ligands | 1 | 2020 | 207 | 0.040 |
Why?
|
| Liver | 1 | 2006 | 1160 | 0.040 |
Why?
|
| Risk | 1 | 2020 | 313 | 0.040 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2020 | 112 | 0.040 |
Why?
|
| Young Adult | 2 | 2020 | 4337 | 0.040 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2020 | 184 | 0.040 |
Why?
|
| Poverty | 1 | 2021 | 219 | 0.040 |
Why?
|
| Radiography, Dental | 1 | 2018 | 5 | 0.040 |
Why?
|
| Radiography, Panoramic | 1 | 2018 | 9 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2020 | 718 | 0.040 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2018 | 37 | 0.040 |
Why?
|
| Syndrome | 1 | 2018 | 253 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 426 | 0.030 |
Why?
|
| Constipation | 1 | 2017 | 37 | 0.030 |
Why?
|
| Vomiting | 1 | 2017 | 73 | 0.030 |
Why?
|
| Esophagus | 1 | 2017 | 83 | 0.030 |
Why?
|
| Diarrhea | 1 | 2017 | 95 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 1686 | 0.030 |
Why?
|
| Food Hypersensitivity | 1 | 2017 | 100 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 1553 | 0.030 |
Why?
|
| Phenotype | 1 | 2018 | 800 | 0.030 |
Why?
|
| Laryngoscopy | 1 | 2015 | 59 | 0.030 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2014 | 8 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2014 | 21 | 0.030 |
Why?
|
| Adult | 2 | 2021 | 14170 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2014 | 142 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2014 | 107 | 0.030 |
Why?
|
| Alopecia | 1 | 2014 | 38 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2014 | 179 | 0.030 |
Why?
|
| Cell Division | 1 | 2014 | 288 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2020 | 1714 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 1048 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 1110 | 0.020 |
Why?
|
| N-Methylaspartate | 1 | 2008 | 18 | 0.020 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2008 | 16 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2008 | 29 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2008 | 44 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2008 | 58 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2008 | 64 | 0.020 |
Why?
|